Cavin-3 is highly expressed in normal breast and lung epithelial cells, while it is absent in breast cancer, lung cancer and gastric cancer, which may be related to its promoter methylation, suggesting that Cavin-3 may play an anticancer role in breast cancer. This evidence concerns the gene CAVIN3 and breast cancer.